Merck KGaA and Artios Pharma announced a global research collaboration that will lead to the development of multiple precision oncology drugs within the next three years. The collaboration will focus on the research of novel approaches to target cancer-causing mutations, with the goal of developing drugs that can be used to treat a variety of cancers.
Bio-Rad Laboratories Inc, a global leader of life science research & clinical diagnostic products, announced the acquisition of Celsee, Inc., a company which offers instruments and consumables for the isolation, detection, and analysis of single cell.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3257
Published Date: Oct 03, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The increasing prevalence of chronic diseases and the growing demand for personalized medicine are creating a strong demand for protein biochips.
The market size of protein biochips is anticipated to attain a CAGR of 15% over the forecast period, i.e., 2024-2036.
High cost of the biochips and the lack of awareness among people about the potential benefits of using protein biochips are major factors that are slowing down the growth of the protein biochips market.
The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
The major players in the market are Dynamic Biosensors GmbH, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., ABTECH Scientific, Inc., Standard BioTools Inc., Merck KGaA, LI-COR, Inc., and others.